# Economic Evaluation of Innovative Molecular Analyses in Onco-haematology

> **NCT03750994** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 3960 (estimated)

## Conditions studied

- Haematological Malignancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03750994
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-18
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 3960 (ESTIMATED)
- **Last updated:** 2018-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03750994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03750994, "Economic Evaluation of Innovative Molecular Analyses in Onco-haematology". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT03750994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*